Bigda J, Mysliwska J, Baran W, Hellmann A, Mysliwski A
Department of Histology, Medical School, Gdansk, Poland.
Leuk Lymphoma. 1993 Mar;9(4-5):371-6. doi: 10.3109/10428199309148536.
Hairy cell leukemia (HCL), a rare B-cell chronic lymphoproliferative disorder, is often accompanied by immune abnormalities. A marked impairment of the natural killer cell-mediated cytotoxicity (NK activity) has been reported in most patients at diagnosis. In the present report a long-term follow-up study of NK activity of splenectomized HCL patients is recorded. Among patients who persisted with stable disease two groups, one with normal NK activity, and another with low NK activity, could be recognized. Patients with progressive stage were characterized by a low NK cytotoxic activity. In vitro tests showed that interferon alpha (IFN-alpha) and interleukin 2 (IL2) could increase the NK activity to normal levels only in HCL patients with stable disease, while in progressive HCL these cytokines showed a significantly decreased effect. These results indicate that cytokine-induced NK cytotoxicity appears to be a valuable parameter in assessing the stage of HCL.
毛细胞白血病(HCL)是一种罕见的B细胞慢性淋巴细胞增殖性疾病,常伴有免疫异常。据报道,大多数患者在诊断时自然杀伤细胞介导的细胞毒性(NK活性)明显受损。本报告记录了对脾切除的HCL患者NK活性的长期随访研究。在病情稳定的患者中,可以识别出两组,一组NK活性正常,另一组NK活性低。进展期患者的特征是NK细胞毒性活性低。体外试验表明,仅在病情稳定的HCL患者中,α干扰素(IFN-α)和白细胞介素2(IL2)可将NK活性提高到正常水平,而在进展性HCL中,这些细胞因子的作用显著降低。这些结果表明,细胞因子诱导的NK细胞毒性似乎是评估HCL分期的一个有价值的参数。